Cargando…
Understanding the impacts of COVID-19 pandemic in people with multiple sclerosis treated with ocrelizumab
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to major challenges in the therapeutic management of patients living with multiple sclerosis (PLwMS), particularly regarding the use of disease-modifying therapies. D...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349416/ https://www.ncbi.nlm.nih.gov/pubmed/34411984 http://dx.doi.org/10.1016/j.msard.2021.103203 |